Most Recent
Generic drug maker Sandoz AG has filed proceedings seeking the revocation of two patents registered in Australia by German pharmaceutical giant Bayer covering its top-selling blood clot drug Xarelto.
Bristol-Myers Squib unit Celgene Corporation has sued Indian generics giant Dr Reddy’s Laboratories for allegedly threatening to infringe eight patents for its blockbuster cancer drug Revlimid, which raked in US$12 billion for the US-based company in revenue last year.
IP Australia has won its appeal of a judge’s decision to allow four Aristocrat patents for its popular Lightning Link electronic poker machine to proceed to grant, with the Full Court finding the invention merely implemented an abstract idea on a computer and was not patentable.
Five years into a preliminary discovery application for a potential patent infringement lawsuit over a biosimilar of its Enbrel medication, Pfizer has partially succeeded in obtaining further documents from Samsung Bioepis.
The maker of Somat dishwashing products has hit back at allegations of trade mark infringement, telling a court the prominent brand name on its range of dishwashing tablets functions as an “unmistakable” point of difference between the company and market leader Finish.
Corrs Chambers Westgarth has nabbed two prominent industrial relations professionals with nearly fifty years combined experience from Herbert Smith Freehills to expand its employment and labour group.
Australian clothing retailer Cotton On has taken rival surf and streetwear brand Ghanda to court over "unjustifiable" and "groundless" accusations of copyright and trade mark infringement.
A trade mark attorney has sued boutique IP firm Marquette, alleging she was fired for complaining about her treatment by a supervisor who had been practising as a lawyer for less than a year.
Drug company Ono Pharmaceutical has faced tough questioning by an appeals court in a fight with IP Australia over a decision that secured it a patent extension for its cancer immunotherapy drug Opdivo.
The a2 Milk Company is paying the price for its descriptive trade name, unsuccessfully opposing registration of a trademark for Reckitt Benckiser subsidiary’s milk-based product, AII.